Ashwagandha for Testosterone and Stress: Clinical Evidence Review

Ashwagandha (Withania somnifera) is the most clinically studied adaptogen for male hormonal health. Unlike many supplement categories where human evidence is thin, ashwagandha has multiple randomized controlled trials showing meaningful effects on cortisol and testosterone. The key qualifier: these effects are clearest in stressed, sleep-deprived, or physically overtrained men — not in men with normal HPA function.

What ashwagandha actually does: the mechanism

Ashwagandha is classified as an adaptogen — a compound that modulates the body's response to stressors rather than acting as a stimulant or sedative. The primary mechanism is modulation of the hypothalamic-pituitary-adrenal (HPA) axis.

The withanolides (bioactive steroidal lactones, primarily withaferin A and withanolide D) in ashwagandha appear to:

• Reduce cortisol secretion in response to physical and psychological stressors
• Normalize ACTH (the pituitary signal that drives cortisol production)
• Reduce the sensitization of stress-response circuits that develops under chronic stress

This is not the same as blocking cortisol entirely. Well-studied adaptogen research distinguishes between reducing excessive stress reactivity versus impairing the acute cortisol response that is functionally necessary.

Cortisol: the primary evidence

Chandrasekhar et al. (2012) [^chandrasekhar2012] conducted the landmark KSM-66 RCT: 64 stressed adults randomized to 300 mg KSM-66 twice daily (600 mg/day total) versus placebo for 60 days. Results:

• Serum cortisol: −27.9% vs −7.9% placebo
• Perceived Stress Scale: −44.0% vs −5.5% placebo
• All secondary stress and anxiety measures improved significantly

The cortisol reduction was specific to stressed individuals — participants had to screen positive for stress-related symptoms to qualify. This is a consistent pattern across ashwagandha research: the effect size scales with baseline HPA dysregulation.

Testosterone: when and how much

Ashwagandha raises testosterone through an indirect pathway: by reducing cortisol, it reduces LH suppression and pregnenolone competition. The testosterone effect is therefore downstream of the cortisol effect — and most pronounced in men with stress-elevated cortisol.

Wankhede et al. (2015) [^wankhede2015] studied resistance-trained men under training stress (a population with elevated cortisol). KSM-66 at 300 mg twice daily for 8 weeks produced:

• Testosterone increase: +96.2 ng/dL vs +18.0 ng/dL placebo (significant)
• Muscle recovery markers improved
• Significantly greater gains in strength and muscle mass

Lopresti et al. (2019) [^lopresti2019] studied aging overweight males (50–70 years) — a population with both age-related testosterone decline and elevated chronic stress. KSM-66 at 600 mg/day for 8 weeks:

• Testosterone: significant increase vs placebo
• DHEA-S: significant increase (upstream androgen precursor)
• Fatigue, vigor, and sexual function improved

What these trials do not show: Testosterone increases in young eugonadal men with normal cortisol and no particular stress load. In that population, ashwagandha's testosterone effect is negligible. The benefit is proportional to the degree of HPA dysregulation present.

Sleep quality

Langade et al. (2019) [^langade2019] demonstrated that KSM-66 (600 mg/day for 10 weeks) significantly improved sleep quality, sleep onset latency, and morning alertness in adults with insomnia. Sleep quality and testosterone are directly linked — testosterone secretion peaks during early-morning REM. Improving sleep is a legitimate mechanism through which ashwagandha may support testosterone independently of its direct cortisol effects.

Physical performance

Bonilla et al. (2021) [^bonilla2021] conducted a Bayesian meta-analysis of ashwagandha supplementation across physical performance trials. Significant improvements in:

• VO2 max
• Muscle strength and endurance
• Recovery from exercise-induced muscle damage

These effects are consistent with reduced exercise-stress cortisol and improved recovery signaling.

Extract standardization: KSM-66 versus generic ashwagandha

Not all ashwagandha products are equivalent. The clinical evidence is concentrated in two proprietary extracts:

KSM-66 (Ixoreal Biomed): Full-spectrum root extract, standardized to ≥5% withanolides. The most-studied extract with the largest body of double-blind RCT data. Manufactured using a unique milk-based extraction process that preserves the full phytochemical profile.

Sensoril (Natreon): Combines root and leaf extract, standardized to ≥10% withanolides and ≥32% oligosaccharides. Higher withanolide concentration but different phytochemical profile. Also well-studied, particularly for stress and cognition.

Generic ashwagandha root powder (unstandardized) has inconsistent withanolide content and limited clinical validation. For therapeutic purposes, use a standardized extract.

Dosing and timing

Dose: 300–600 mg/day of KSM-66 or equivalent standardized extract. The Chandrasekhar and Wankhede trials both used 600 mg/day (split 300 mg twice daily). 300 mg/day may be sufficient for mild stress; 600 mg/day is the validated therapeutic dose.

Timing: Evening dosing (or splitting AM/PM) is more consistent with targeting the elevated evening cortisol pattern characteristic of chronic stress. Taking it 30–60 minutes before bed is a common and practical approach.

Onset: Stress and sleep improvements begin within 2–4 weeks. Testosterone and physical performance effects are typically measured at 8 weeks in trials. Full benefit requires a sustained 8–12 week commitment.

Cycling: Not required based on current evidence. Ashwagandha does not produce tolerance in the classic pharmacological sense. Some practitioners cycle 8 weeks on / 2 weeks off as a precaution, but there is no data supporting this as necessary.

Safety profile

Ashwagandha has a well-documented safety record at standard doses. Reported side effects in clinical trials are mild and uncommon: gastrointestinal discomfort (taking with food eliminates this in most cases), drowsiness (most common with evening dosing — use it; this is partly how it improves sleep).

Thyroid: Ashwagandha has mild thyroid-stimulating activity. Men with hyperthyroidism or autoimmune thyroid conditions should use caution and monitor thyroid function. For men with normal thyroid function, this is not a concern.

Interactions: Limited known drug interactions. Avoid combining with sedative medications unless monitored. Not recommended during immunosuppressive therapy due to immunostimulant properties.

Who benefits and who does not

Most likely to benefit:

• Men with documented or suspected elevated cortisol (chronic stress, poor sleep, high training volume)
• Men with age-related testosterone decline (40+) combined with poor stress resilience
• Men in caloric restriction or aggressive training programs with slow recovery

Unlikely to benefit significantly:

• Young men with normal HPA function and no particular stress load
• Men with primary hypogonadism (testicular failure) — ashwagandha works via HPA, not directly on testicular function
• Men expecting the effect size of TRT — the testosterone increases are real but modest (roughly 10–20% from a suppressed baseline, not pharmacological supraphysiologic levels)